We are live on ! Find out more
ALLK

Allakos

Delisted

ALLK was delisted on the 15th of May, 2025.

141 hedge funds and large institutions have $334M invested in Allakos in 2021 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 51 increasing their positions, 31 reducing their positions, and 60 closing their positions.

New
Increased
Maintained
Reduced
Closed

74% more call options, than puts

Call options by funds: $20.7M | Put options by funds: $11.9M

65% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 31

12% less funds holding

Funds holding: 161141 (-20)

32% less first-time investments, than exits

New positions opened: 41 | Existing positions closed: 60

60% less funds holding in top 10

Funds holding in top 10: 52 (-3)

93% less capital invested

Capital invested by funds: $4.73B → $334M (-$4.39B)

Holders
141
Holders Change
-20
Holders Change %
-12.42%
% of All Funds
2.17%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.03%
New
41
Increased
51
Reduced
31
Closed
60
Calls
$20.7M
Puts
$11.9M
Net Calls
+$8.79M
Net Calls Change
-$30.3M
Name Holding Trade Value Shares
Change
Change in
Stake
Jennison Associates
26
Jennison Associates
New York
$2.65M +$8.26M +100,889 +59%
Squarepoint
27
Squarepoint
New York
$2.6M +$21.8M +265,700 New
Charles Schwab
28
Charles Schwab
California
$2.44M +$478K +5,836 +2%
T. Rowe Price Associates
29
T. Rowe Price Associates
Maryland
$2.37M +$18.5M +226,340 +1,433%
Walleye Capital
30
Walleye Capital
New York
$1.83M +$15.3M +187,125 New
Bank of America
31
Bank of America
North Carolina
$1.77M +$12.7M +155,029 +598%
SB
32
Samsara BioCapital
California
$1.69M
TI
33
Trexquant Investment
Connecticut
$1.67M +$14M +170,302 New
FFM
34
Fairmount Funds Management
Pennsylvania
$1.44M -$2.31M -28,173 -16%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$1.39M +$136K +1,660 +1%
OQS
36
Occudo Quantitative Strategies
Florida
$1.24M +$10.2M +124,396 +4,901%
JP Morgan Chase
37
JP Morgan Chase
New York
$1.23M +$8.2M +100,113 +388%
Citigroup
38
Citigroup
New York
$1.16M +$5.68M +69,277 +140%
PFM
39
Privium Fund Management
Netherlands
$1.04M +$8.5M +103,699 New
PP
40
PDT Partners
New York
$940K +$7.87M +96,046 New
EAM
41
Eventide Asset Management
Massachusetts
$882K -$44.2M -539,916 -86%
N
42
Natixis
France
$841K -$1.82M -22,266 -21%
UBS Group
43
UBS Group
Switzerland
$836K +$6.91M +84,339 +8,562%
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
$796K +$6.14M +75,003 +1,192%
Rafferty Asset Management
45
Rafferty Asset Management
New York
$709K +$3.51M +42,845 +145%
Swiss National Bank
46
Swiss National Bank
Switzerland
$698K +$24.6K +300 +0.4%
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$693K -$594K -7,249 -9%
Group One Trading
48
Group One Trading
Illinois
$669K +$5.02M +61,329 +881%
AA
49
ALPS Advisors
Colorado
$615K +$5.15M +62,858 New
Nomura Holdings
50
Nomura Holdings
Japan
$580K +$4.84M +59,033 New

ALLK Hedge Fund Activity: Q4 2021 in Review

141 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Allakos (ALLK) for Q4 2021, worth a combined $334M — down 93% from $4.73B a quarter earlier.

Sellers outnumbered buyers: 60 funds closed out of ALLK and 41 opened new positions — a net loss of 19 holders — while 31 trimmed existing stakes and 51 added.

The largest buyer was Millennium Management, adding an estimated $156M. The largest seller was Capital World Investors, exiting entirely with an estimated $700M sold.

  • 141 institutional investors held Allakos (ALLK) as of Q4 2021, down from 161 in Q3 2021.
  • Funds reported $334M of Allakos stock for Q4 2021, down 93% quarter-over-quarter.
  • 41 funds opened new Allakos positions in Q4 2021 and 60 closed out, a net change of -19 holders.
  • The largest Allakos buyer in Q4 2021 was Millennium Management, an estimated $156M added.
  • The largest Allakos seller in Q4 2021 was Capital World Investors, an estimated $700M sold.

Based on aggregated 13F filings for Q4 2021.